1. Clinical summary of ACPA literature in early and established rheumatoid arthritis.
Clinical summary of ACPA literature in early and established rheumatoid arthritis. Anti-Sa ELISA (Euroimmun): anticitrullinated vimentin (target is an in vitro citrullinated native protein); anti-CCP ELISA (several companies): anticyclic citrullinated peptide (target is an in vitro synthetic peptide); anti-MCV ELISA (Orgentec): anti-mutated citrullinated vimentin (target is a multi-mutated recombinant vimentin molecule made in Escherichia coli and secondarily citrullinated in vitro). RF: rheumatoid factor.
HENRI A. MÉNARD J Rheumatol 2015;42:
©2015 by The Journal of Rheumatology